Marie Ng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marie Ng has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Maigeng Zhou
National Center for Chronic Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
4 shared publications - Emmanuela Gakidou
Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA
2 shared publications Jiang-Mei Liu
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 100050, China
2 shared publicationsJinling You
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
2 shared publicationsLijun Wang
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
2 shared publications- Luisa Sorio Flor
Institute for Health Metrics and Evaluation, University of Washington, Seattle, USA
2 shared publications
Latest Publications
- Open Access
- 26 February 2026
- Published by Elsevier in SSRN Electronic Journal
Global, Regional, and National Burden of Tuberculosis and Multidrug-Resistant Tuberculosis in the Context of HIV/AIDS, 1990–2023: A Systematic Analysis for the Global Burden of Disease Study 2023
Background: A preventable, treatable, and curable infectious disease, tuberculosis (TB) is a leading global cause of death from a single infectious agent. Recent reductions in global health funding have threatened TB control, making comprehensive assessment of TB, HIV-related TB, and drug-resistant TB burdens prior to these disruptions essential for shaping effective responses. Using results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023, this study assesses TB and multidrug-resistant tuberculosis (MDR-TB) burden across 204 countries and territories. Methods: We quantified TB mortality and morbidity, disaggregated by HIV status, drug-resistance, and risk-attributable burden. TB mortality was analysed using the Cause of Death Ensemble modelling platform with global vital registrations, surveillance, and verbal autopsy data. For TB morbidity estimation, we simultaneously model incidence, prevalence, and mortality by age and sex using DisMod-MR 2.1, which ensures consistency between data for different parameters. A population attributable fraction (PAF) approach was applied to stratify morbidity and mortality estimates by HIV and drug-resistance status. For risk factor analysis, comparative risk assessment framework was used and PAFs were derived for alcohol use, smoking, and diabetes to determine the portion of TB burden associated with these risk factors. Findings: In 2023, there were an estimated 9.11 million (95% UI 8.04–10.3) incident cases of all-form TB, 1.22 million (0.98–1.49) deaths, and 54.6 million (43.8–65.5) DALYs. HIV-related TB comprised 781 000 (690 000–879 000) incident cases and 210 000 (142 000–279 000) deaths, contributing 11.0 million (7.56–14.3) DALYs. MDR‑TB accounted for 466 000 (198 000–1 080 000) incident cases, 102 000 (31 700–238 000) deaths, and 3.96 million (1.31–9.01) DALYs. From 2015 to 2023, global all-form TB incidence rates declined by 19.2% (17.8–20.5) and deaths by 22.6% (4.7–35.7); declines were larger for drug‑susceptible TB than for MDR‑TB. Sub‑Saharan Africa and south Asia observed the highest mortality burdens; progress was uneven, with stagnation in Latin America and the Caribbean. Removing smoking, alcohol use, and high fasting plasma glucose would reduce global TB deaths to 768 000 (592 000–970 000), YLLs to 30.0 million (23.3–38.3), and DALYs to 34.9 million (27.8–43.8); MDR‑TB deaths would decrease to 77 200 (23 400–183 000), with a corresponding reduction in global DALYs to 3.12 million (1.30–7.39). Interpretation: Global progress toward End TB targets is disparate and fragile. While many regions achieved meaningful gains, others have stagnated in recent years. The complexity of TB prevention is amplified by divergent MDR-TB trends, the persistent burden of HIV, and growing exposure to modifiable risk factors. Recent volatility in global health financing threatens to further destabilise this vulnerable epidemiological landscape; concerted action is urgently needed to temper disruptions and preserve progress.
- 26 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessGlobal, Regional, and National Burden of Tuberculosis and Multidrug-Resistant Tuberculosis in the Context of HIV/AIDS, 1990–2023: A Systematic Analysis for the Global Burden of Disease Study 2023
Background: A preventable, treatable, and curable infectious disease, tuberculosis (TB) is a leading global cause of death from a single infectious agent. Recent reductions in global health funding have threatened TB control, making comprehensive assessment of TB, HIV-related TB, and drug-resistant TB burdens prior to these disruptions essential for shaping effective responses. Using results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023, this study assesses TB and multidrug-resistant tuberculosis (MDR-TB) burden across 204 countries and territories. Methods: We quantified TB mortality and morbidity, disaggregated by HIV status, drug-resistance, and risk-attributable burden. TB mortality was analysed using the Cause of Death Ensemble modelling platform with global vital registrations, surveillance, and verbal autopsy data. For TB morbidity estimation, we simultaneously model incidence, prevalence, and mortality by age and sex using DisMod-MR 2.1, which ensures consistency between data for different parameters. A population attributable fraction (PAF) approach was applied to stratify morbidity and mortality estimates by HIV and drug-resistance status. For risk factor analysis, comparative risk assessment framework was used and PAFs were derived for alcohol use, smoking, and diabetes to determine the portion of TB burden associated with these risk factors. Findings: In 2023, there were an estimated 9.11 million (95% UI 8.04–10.3) incident cases of all-form TB, 1.22 million (0.98–1.49) deaths, and 54.6 million (43.8–65.5) DALYs. HIV-related TB comprised 781 000 (690 000–879 000) incident cases and 210 000 (142 000–279 000) deaths, contributing 11.0 million (7.56–14.3) DALYs. MDR‑TB accounted for 466 000 (198 000–1 080 000) incident cases, 102 000 (31 700–238 000) deaths, and 3.96 million (1.31–9.01) DALYs. From 2015 to 2023, global all-form TB incidence rates declined by 19.2% (17.8–20.5) and deaths by 22.6% (4.7–35.7); declines were larger for drug‑susceptible TB than for MDR‑TB. Sub‑Saharan Africa and south Asia observed the highest mortality burdens; progress was uneven, with stagnation in Latin America and the Caribbean. Removing smoking, alcohol use, and high fasting plasma glucose would reduce global TB deaths to 768 000 (592 000–970 000), YLLs to 30.0 million (23.3–38.3), and DALYs to 34.9 million (27.8–43.8); MDR‑TB deaths would decrease to 77 200 (23 400–183 000), with a corresponding reduction in global DALYs to 3.12 million (1.30–7.39). Interpretation: Global progress toward End TB targets is disparate and fragile. While many regions achieved meaningful gains, others have stagnated in recent years. The complexity of TB prevention is amplified by divergent MDR-TB trends, the persistent burden of HIV, and growing exposure to modifiable risk factors. Recent volatility in global health financing threatens to further destabilise this vulnerable epidemiological landscape; concerted action is urgently needed to temper disruptions and preserve progress.
- Open Access
- 24 December 2025
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 139 (7) , 1101-1103
National and provincial disease burden of childhood asthma in China, 2010–2021: A systematic analysis of the Global Burden of Disease Study 2021
- 24 December 2025
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 139 (7) , 1101-1103
Open AccessNational and provincial disease burden of childhood asthma in China, 2010–2021: A systematic analysis of the Global Burden of Disease Study 2021
- Open Access
- 15 August 2025
- Published by Elsevier in Military Medical Research
- Vol. 12 (1) , 49
Sudden cardiac arrest mortality in China: temporal trends and risk factors
- 15 August 2025
- Published by Elsevier in Military Medical Research
- Vol. 12 (1) , 49
Open AccessSudden cardiac arrest mortality in China: temporal trends and risk factors
- Top Cited PapersOpen Access
- 2 June 2025
- Published by Elsevier in Military Medical Research
- Vol. 12 (1) , 1-15
The national and provincial prevalence and non-fatal burdens of diabetes in China from 2005 to 2023 with projections of prevalence to 2050
- 2 June 2025
- Published by Elsevier in Military Medical Research
- Vol. 12 (1) , 1-15
Top Cited PapersOpen AccessThe national and provincial prevalence and non-fatal burdens of diabetes in China from 2005 to 2023 with projections of prevalence to 2050
- 6 May 2025
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 69 (2) , 107644
Foregone Preventive Care and Unmet Mental Healthcare Needs Among U.S. Youth
- 6 May 2025
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 69 (2) , 107644
Foregone Preventive Care and Unmet Mental Healthcare Needs Among U.S. Youth
- Open Access
- 7 May 2024
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 46, 101083
Urban-rural differences in the association between occupational physical activity and mortality in Chinese working population: evidence from a nationwide cohort study
- 7 May 2024
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 46, 101083
Open AccessUrban-rural differences in the association between occupational physical activity and mortality in Chinese working population: evidence from a nationwide cohort study
- Open Access
- 7 May 2024
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 47, 101085
The association between education and premature mortality in the Chinese population: a 10-year cohort study
- 7 May 2024
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 47, 101085
Open AccessThe association between education and premature mortality in the Chinese population: a 10-year cohort study
- Open Access
Endline Assessment of a Community-Based Program on Hypertension and Diabetes Management in Brazil
Background: Brazil HealthRise community-based program focused on improving technologies for care coordination, developing the local workforce, and identifying and educating individuals with hypertension and diabetes. Objectives: To assess the impact of HealthRise on hypertension and diabetes management among patients in the region of Teófilo Otoni (TO) and in the city of Vitória da Conquista (VC). Methods: Grantees routinely collected patient-level clinical in intervention areas from March 2017 to December 2018; endline qualitative interviews were conducted with patients, providers, administrators, and policymakers in both intervention and comparison sites. Paired t-tests were employed to measure the potential impact of the program on reducing systolic blood pressure (SBP) and hemoglobin A1c (HbA1c) between baseline and endline, and on increasing the percentage of enrollees meeting clinical targets (SBP < 140 mmHg for hypertension; < 8% HbA1c for diabetes). We analyzed qualitative data using thematic coding. Results: Across sites, 2,764 hypertension patients and 244 diabetes patients were followed through endline. Participants experienced reductions in SBP in TO (−1.9 mmHg [−3.1;−0.7]) and VC (−4,2 mmHg [−5.2;−3.1]); more hypertension patients met treatment targets in these locations (TO: +3.9 percentage-points [0.4;7.2]; VC: +10.5 percentage-points [7.81;13.2]) by endline. HbA1c decreased in TO (−0.6 [−0.9;−0.4]) and VC (−0.9 [−1.4;−0.5]), and more individuals presented HbA1c < 8% by endline (TO: +10.2 percentage-points [3.8, 16.6]; VC: +25 percentage-points [12.2, 37.8]). Qualitative data pointed to overall enthusiasm for new technologies and care routine implemented by HealthRise, but challenges regarding program implementation, integration with other levels of care, and social determinants of health persisted. Conclusions: Program showed positive effects on hypertension and diabetes outcomes. Community-based health interventions can help bridge healthcare gaps, but their full impact will remain limited until multisectoral policies and actions address underlying structural and social determinants of health more effectively.
Open AccessEndline Assessment of a Community-Based Program on Hypertension and Diabetes Management in Brazil
Background: Brazil HealthRise community-based program focused on improving technologies for care coordination, developing the local workforce, and identifying and educating individuals with hypertension and diabetes. Objectives: To assess the impact of HealthRise on hypertension and diabetes management among patients in the region of Teófilo Otoni (TO) and in the city of Vitória da Conquista (VC). Methods: Grantees routinely collected patient-level clinical in intervention areas from March 2017 to December 2018; endline qualitative interviews were conducted with patients, providers, administrators, and policymakers in both intervention and comparison sites. Paired t-tests were employed to measure the potential impact of the program on reducing systolic blood pressure (SBP) and hemoglobin A1c (HbA1c) between baseline and endline, and on increasing the percentage of enrollees meeting clinical targets (SBP < 140 mmHg for hypertension; < 8% HbA1c for diabetes). We analyzed qualitative data using thematic coding. Results: Across sites, 2,764 hypertension patients and 244 diabetes patients were followed through endline. Participants experienced reductions in SBP in TO (−1.9 mmHg [−3.1;−0.7]) and VC (−4,2 mmHg [−5.2;−3.1]); more hypertension patients met treatment targets in these locations (TO: +3.9 percentage-points [0.4;7.2]; VC: +10.5 percentage-points [7.81;13.2]) by endline. HbA1c decreased in TO (−0.6 [−0.9;−0.4]) and VC (−0.9 [−1.4;−0.5]), and more individuals presented HbA1c < 8% by endline (TO: +10.2 percentage-points [3.8, 16.6]; VC: +25 percentage-points [12.2, 37.8]). Qualitative data pointed to overall enthusiasm for new technologies and care routine implemented by HealthRise, but challenges regarding program implementation, integration with other levels of care, and social determinants of health persisted. Conclusions: Program showed positive effects on hypertension and diabetes outcomes. Community-based health interventions can help bridge healthcare gaps, but their full impact will remain limited until multisectoral policies and actions address underlying structural and social determinants of health more effectively.
- Top Cited PapersOpen Access
- 21 January 2021
- Published by Springer Nature in Nature Medicine
- Vol. 27 (2) , 239-243
The effects of tobacco control policies on global smoking prevalence
Substantial global effort has been devoted to curtailing the tobacco epidemic over the past two decades, especially after the adoption of the Framework Convention on Tobacco Control1 by the World Health Organization in 2003. In 2015, in recognition of the burden resulting from tobacco use, strengthened tobacco control was included as a global development target in the 2030 Agenda for Sustainable Development2. Here we show that comprehensive tobacco control policies—including smoking bans, health warnings, advertising bans and tobacco taxes—are effective in reducing smoking prevalence; amplified positive effects are seen when these policies are implemented simultaneously within a given country. We find that if all 155 countries included in our counterfactual analysis had adopted smoking bans, health warnings and advertising bans at the strictest level and raised cigarette prices to at least 7.73 international dollars in 2009, there would have been about 100 million fewer smokers in the world in 2017. These findings highlight the urgent need for countries to move toward an accelerated implementation of a set of strong tobacco control practices, thus curbing the burden of smoking-attributable diseases and deaths.
- 21 January 2021
- Published by Springer Nature in Nature Medicine
- Vol. 27 (2) , 239-243
Top Cited PapersOpen AccessThe effects of tobacco control policies on global smoking prevalence
Substantial global effort has been devoted to curtailing the tobacco epidemic over the past two decades, especially after the adoption of the Framework Convention on Tobacco Control1 by the World Health Organization in 2003. In 2015, in recognition of the burden resulting from tobacco use, strengthened tobacco control was included as a global development target in the 2030 Agenda for Sustainable Development2. Here we show that comprehensive tobacco control policies—including smoking bans, health warnings, advertising bans and tobacco taxes—are effective in reducing smoking prevalence; amplified positive effects are seen when these policies are implemented simultaneously within a given country. We find that if all 155 countries included in our counterfactual analysis had adopted smoking bans, health warnings and advertising bans at the strictest level and raised cigarette prices to at least 7.73 international dollars in 2009, there would have been about 100 million fewer smokers in the world in 2017. These findings highlight the urgent need for countries to move toward an accelerated implementation of a set of strong tobacco control practices, thus curbing the burden of smoking-attributable diseases and deaths.
- Open Access
- 1 January 2016
- Published by Inderscience Publishers in International Journal of Quantitative Research in Education
- Vol. 3 (1/2) , 24
Testing for mediation effects under non-normality and heteroscedasticity: a comparison of classic and modern methods
Analysis of mediation effects is common in educational research. The most popular methods for testing mediation effects are the causal steps approach proposed by Baron and Kenny (1986), and Sobel's test (1982). Numerous studies have pointed out limitations of these classic procedures, and modern methods based on bootstrap techniques have been proposed. However, the robustness of these modern methods has not been thoroughly understood. In this study, we evaluate the impact of non-normality and heteroscedasticity on the performance of both classic and modern methods for mediation analysis. Results from our simulation show that non-normality and heteroscedasticity can substantially undermine the statistical power of all methods. Nevertheless, modern bootstrap techniques are preferred over classic methods.
- 1 January 2016
- Published by Inderscience Publishers in International Journal of Quantitative Research in Education
- Vol. 3 (1/2) , 24
Open AccessTesting for mediation effects under non-normality and heteroscedasticity: a comparison of classic and modern methods
Analysis of mediation effects is common in educational research. The most popular methods for testing mediation effects are the causal steps approach proposed by Baron and Kenny (1986), and Sobel's test (1982). Numerous studies have pointed out limitations of these classic procedures, and modern methods based on bootstrap techniques have been proposed. However, the robustness of these modern methods has not been thoroughly understood. In this study, we evaluate the impact of non-normality and heteroscedasticity on the performance of both classic and modern methods for mediation analysis. Results from our simulation show that non-normality and heteroscedasticity can substantially undermine the statistical power of all methods. Nevertheless, modern bootstrap techniques are preferred over classic methods.